Afinitor is a brand-name drug that’s prescribed for certain seizures, cancers, and tumors. Afinitor contains the active ingredient everolimus and may not be safe to take during pregnancy and ...

Afinitor (everolimus) is a prescription drug that’s used to treat some types of cancer, seizures, and certain tumors. This drug can interact with other medications and some supplements.

Patients with previously treated advanced clear cell renal cell carcinoma (RCC) — a type of kidney cancer — experienced improvements in progression and response via treatment with Welireg (belzutifan) ...

While Welireg (belzutifan) has outperformed Afinitor (everolimus) in OS at 12 months and 24 months, the results have not achieved statistical significance. The OS gap between Welireg and Afinitor ...

Regarding distributions, we view Novartis’ dividends and share repurchases as about right. Novartis has generally targeted close to a 50% payout in dividends as a percentage of normalized earnings, ...

An expert provides answers to readers’ questions regarding different aspects of the kidney cancer experience, such as protein intake and clinical trials.

Belzutifan improved progression-free survival and objective response rate compared to everolimus in previously treated ...

and cancer chemotherapy Afinitor (everolimus) under Medicare. Novartis said last year it had set aside $700 million for a possible settlement for the allegations, which cover a period between 2002 ...

Treatment with belzutifan (Welireg) demonstrated significant benefits over everolimus (Afinitor) in treating advanced clear cell renal cell carcinoma (RCC). Specifically, patients who received ...

Regarding chromophobe RCC, Albiges showed data on the combinations of lenvatinib/everolimus (Afinitor) (n = 9) and lenvatinib/pembrolizumab (n = 29), which reported an ORR of 44% vs 34.5%, ...